Cytological misdiagnosis of high-grade medullary thyroid carcinoma with papillary-like nuclear features: A case report
1. Trimboli P, Crescenzi A. Diagnosing medullary thyroid carcinoma is facilitated by measuring calcitonin in FNA washout fluids: Alea iacta est. Cancer Cytopathol. 2024;132(3):139. doi: 10.1002/cncy.22797.
2. Ogmen BE, Ince N, Aksoy Altınboga A, et al. An old friend, a new insight: Calcitonin measurement in serum and aspiration needle washout fluids significantly increases the early and accurate detection of medullary thyroid cancer. Cancer Cytopathol. 2024 Mar;132(3):161-168. doi: 10.1002/cncy.22779.
3. Liu S, Zhao H, Li X. Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update. Cancer Manag Res. 2024;16:299-310. doi: 10.2147/CMAR.S440477.
4. Nikas IP, Kazamias G, Vrontaki M, Rapti AS, Mastorakis E. Medullary thyroid carcinoma diagnosed with liquid-based cytology and immunocytochemistry. J Immunoassay Immunochem. 2022;43(5):502-515. doi: 10.1080/15321819.2022.2070025.
5. Liu CY, Chen CC, Bychkov A, et al. Constitutive Cytomorphologic Features of Medullary Thyroid Carcinoma Using Different Staining Methods. Diagnostics (Basel). 2021;11(8):1396. doi: 10.3390/diagnostics11081396.
6. Ahmed M, Abi-Raad R, Fu L, Holt EH, Adeniran AJ, Cai G. Performing Calcitonin Immunocytochemistry on an Additional ThinPrep Slide in Fine-Needle Aspiration Diagnosis of Medullary Thyroid Carcinoma. Am J Clin Pathol. 2022;157(3):426-433. doi: 10.1093/ajcp/aqab141.
7. Trimboli P, Treglia G, Guidobaldi L, et al. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. Clin Endocrinol (Oxf). 2015;82(2):280-285. doi: 10.1111/cen.12563.
8. Kang M, Kim NR, Seok JY. Non-papillary thyroid carcinoma diagnoses in The Bethesda System for Reporting Thyroid Cytopathology categories V and VI: An institutional experience. Ann Diagn Pathol. 2024;71:152263. doi: 10.1016/j.anndiagpath.2023.152263.
9. Agarwal C, Raychaudhuri S, Batra A, Pujani M, Dhingra S. Medullary carcinoma of thyroid mimicking Hurthle cell neoplasm on cytology: a diagnostic dilemma. Diagn Cytopathol. 2019;47(9):943-947. doi: 10.1002/dc.24220.
10. Kaushal S, Iyer VK, Mathur SR, Ray R. Fine needle aspiration cytology of medullary carcinoma of the thyroid with a focus on rare variants: a review of 78 cases. Cytopathology. 2011;22(2):95-105. doi: 10.1111/j.1365-2303.2010.00747.x.
11. Schreiner AM, Yang GC. Medullary thyroid carcinoma presenting as rectangular cell type on fine-needle aspiration. Diagn Cytopathol. 2009;37(3):213-216. doi: 10.1002/dc.21041.
12. Trivedi D, George L. An Aggressive Form of Medullary Thyroid Carcinoma-Melanocytic Subtype: A Case Report. Cureus. 2023;15(12):e50310. doi: 10.7759/cureus.50310.
13. Yamao N, Hirokawa M, Suzuki A, et al. High-grade medullary thyroid carcinoma with papillary-like nuclear features: A report of five cases. Diagn Cytopathol. 2024;52(1):58-64. doi: 10.1002/dc.25243.
14. Aksoy YA, Xu B, Viswanathan K, et al. Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma. Histopathology. 2024;84(6):947-959. doi: 10.1111/his.15141.
15. Wang Z, Fan X, Zha X, et al. A Proposed Modified Staging System for Medullary Thyroid Cancer: A SEER Analysis With Multicenter Validation. Oncologist. 2024;29(1):e59-e67. doi: 10.1093/oncolo/oyad165.
16. Najdawi F, Ahmadi S, Capelletti M, Dong F, Chau NG, Barletta JA. Evaluation of grade in a genotyped cohort of sporadic medullary thyroid carcinomas. Histopathology. 2021;79(3):427-436. doi: 10.1111/his.14370.
17. Toraih E, Hussein M, Anker A, et al. Survival Outcomes of Medullary Thyroid Cancer With and Without Amyloid Deposition. Endocr Pract. 2024;30(4):311-318. doi: 10.1016/j.eprac.2024.01.001.
18. Fuchs TL, Nassour AJ, Glover A, et al. A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis. Am J Surg Pathol. 2020;44(10):1419-1428. doi: 10.1097/PAS.0000000000001505.
19. Alzumaili B, Xu B, Spanheimer PM, et al. Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome. Mod Pathol. 2020;33(9):1690-1701. doi: 10.1038/s41379-020-0532-1.
20. Xu B, Fuchs TL, Ahmadi S, et al. International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma. J Clin Oncol. 2022;40(1):96-104. doi: 10.1200/JCO.21.01329.
21. Dvoráková S, Václavíková E, Sýkorová V, et al. New multiple somatic mutations in the RET proto-oncogene associated with a sporadic medullary thyroid carcinoma. Thyroid. 2006;16(3):311-316. doi: 10.1089/thy.2006.16.311.

Copyright (c) 2025 The European Research Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Article Information
- Article Type Case Report
- Submitted February 21, 2026
- Published November 3, 2025
- Issue Vol. 11 No. 6 (2025)
- Section Case Report